Multiplex pyrosequencing of two polymorphisms in DNA repair gene XRCC1

Journal of Molecular Diagnostics

Volumn 8, Issue 4, 2006, Pages 444-448

  van der Straaten, Tahar ^a   Kweekel, Dinemarie ^a   Tiller, Marco ^a   Bogaartz, Judith ^a   Guchelaar, Henk Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ARGININE; CYSTEINE; DNA; EXCISION REPAIR ENZYME XRCC1; GLUTAMINE; PLATINUM DERIVATIVE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; COLORECTAL CANCER; CONTROLLED STUDY; DNA ISOLATION; DNA REPAIR; ENZYME ACTIVITY; ENZYME POLYMORPHISM; EXCISION REPAIR; GENE DELETION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC CODE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLEX PYROSEQUENCE ASSAY; MUTATION RATE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; RELIABILITY; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOP CODON;

EID: 33748601578     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2006.060018     Document Type: Article

References (18)

1. Tuynman JB, Hulscher JB, Steller EP, van Lanschot JJ, Richel DJ: [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma]. Ned Tijdschr Geneeskd 2003, 147: 2207-2212
2. Goldberg RM: Advances in the treatment of metastatic colorectal cancer. Oncologist 2005, 10(Suppl 3):40-48
3. Seufferlein T, Boehm BO: The impact of pharmacogenomics on gastrointestinal cancer therapy. Pharmacogenomics 2002, 3:625-633
4. van Glabbeke M, Renard J, Pinedo HM, Cavalli F, Vermorken J, Sessa C, Abele R, Clavel M, Monfardini S: Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG). Eur J Cancer Clin Oncol 1988, 24:255-262
5. Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ: A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res 2001, 61:8654-8658
6. Stoehlmacher J, Ghaderi V, lobal S, Groshen S, Tsao-Wei D, Park D, Lenz HJ: A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Res 2001, 21:3075-3079
7. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA: XRCCI polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999, 59:2557-2561
8. Siciliano MJ, Carrano AV, Thompson LH: Assignment of a human DNA-repair gene associated with sister-chromatid exchange to chromosome 19. Mutat Res 1986, 174:303-308
9. Thompson LH, Brookman KW, Jones NJ, Allen SA, Carrano AV: Molecular cloning of the human XRCC1 gene, which corrects detective DNA strand break repair and sister chromatid exchange. Mol Cell Biol 1990, 10:6160-6171
10. Hartwig A, Blessing H, Schwerdtle T, Walter I: Modulation of DNA repair processes by arsenic and selenium compounds. Toxicology 2003, 193:161-169
11. Shall S, de Murcia G: Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat Res 2000, 460:1-15
12. Shen MR, Jones IM, Mohrenweiser H: Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998, 58:604-608
13. Stoehlmacher J, Ghaderi V, lobal S, Groshen S, Tsao-Wei D, Park D, Lenz HJ: A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Res 2001, 21:3075-3079
14. Okano S, Lan L, Caldecott KW, Mori T, Yasui A: Spatial and temporal cellular responses to single-strand breaks in human cells. Mol Cell Biol 2003, 23:3974-3981
15. Ame JC, Spenlehauer C, de Murcia G: The PARP superfamily. Bioessays 2004, 26:882-893
16. El Khamisy SF, Masutani M, Suzuki H, Caldecott KW: A requirement for PARP-1 for the assembly or stability of XRCCI nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res 2003, 31:5526-5533
17. Eriksson J, Gharizadeh B, Nourizad N, Nyren P: 7-Deaza-2′-deoxyadenosine-5′- triphosphate as an alternative nucleotide for the pyrosequencing technology. Nucleosides Nucleotides Nucleic Acids 2004, 23:1583-1594
18. Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC: xPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 2004, 22:2594-2601